Australia's Prana shares jump 26 pct after drug trial success

SYDNEY, Feb 19 (Reuters) - Australia's Prana Biotechnology Ltd PBT.AX PRAN.O shares jumped as much as 26 percent on Wednesday, after the company said its experimental brain disorder drug improved cognitive function in a study on patients with Huntington's disease.

Prana shares last traded up 24.6 percent at A$1.14 at 2312 GMT.

(Reporting by Maggie Lu Yueyang)

((maggie.luyueyang@thomsonreuters.com)(+61 2 93731819)(Reuters Messaging: maggie.luyueyang.thomsonreuters.com@reuters.net))

Keywords: AUSTRALIA PRANA/